Page last updated: 2024-12-05

bromthymol blue

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bromthymol Blue: A pH sensitive dye that has been used as an indicator in many laboratory reactions. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bromothymol blue : A member of the class of 2,1-benzoxathioles that is 2,1-benzoxathiole 1,1-dioxide in which both of the hydrogens at position 3 have been substituted by 3-bromo-4-hydroxy-5-isopropyl-2-methylphenyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6450
CHEMBL ID3392578
CHEBI ID86155
SCHEMBL ID63937
MeSH IDM0002959

Synonyms (73)

Synonym
AC-12375
dibromothymolsulfonphthalein
thymol,6'-(3h-2,1-benzoxathiol-3-ylidene)bis[2-bromo-, s,s-dioxide
phenol,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-, s,s-dioxide
nsc-7819
3,3'-dibromothymolsulfonphthalein
einecs 200-971-2
phenol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-methylethyl)-, s,s-dioxide
phenol, 4,4'-(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-methylethyl)-
phenol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-met- hylethyl)-, s,s-dioxide
nsc 7819
4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-met- hylethyl)phenol) s,s-dioxide
brn 0373934
thymol, 6,6'-(3h-2,1-benzoxathiol-3-ylidene)bis(2-bromo-, s,s-dioxide
thymol, 6,6'-(3h-2, {1-benzoxathiol-3-ylidene)bis[2-bromo-,} s,s-dioxide
bromthymol blue
76-59-5
dibromothymolsulfophthalein
3, 3'-dibromothymolsulfonphthalein
phenol, 4,4'-(3h-2, {1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-,} s,s-dioxide
2-bromo-4-[3-(3-bromo-4-hydroxy-5-isopropyl-2-methyl-phenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-6-isopropyl-3-methyl-phenol
bromothymol blue
nsc7819
bromothymol blue, acs reagent, dye content 95 %
B0658
B0113
B0657
AKOS000813837
NCGC00187594-01
4,4'-(1,1-dioxido-3h-2,1-benzoxathiole-3,3-diyl)bis[2-bromo-3-methyl-6-(propan-2-yl)phenol]
STL280457
5-19-03-00461 (beilstein handbook reference)
unii-vgu4lm0h96
vgu4lm0h96 ,
BP-13280
SCHEMBL63937
bromthymol blue [mi]
bromothymol blue [inci]
3,3'-dibromothymolsulfophthalein
DTXSID3058799
J-610060
bromothymol blue indicator ph.eur
phenol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-, s,s-dioxide
thymol, 6,6'-(3h-2,1-benzoxathiol-3-ylidene)bis*2-bromo-, s,s-dioxide
thymol, 6,6'-(3h-2,1-benzoxathiol-3-ylidene)bis[2-bromo-, s,s-dioxide
phenol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis*2-bromo-3-methyl-6-(1-methylethyl)-, s,s-dioxide
phenol,4,4'-(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-
bromothymol sulfone phthalein
4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-methylethyl)phenol) s,s-dioxide
3,3-bis[3-bromo-4-hydroxy-2-methyl-5-(propan-2-yl)phenyl]-2,1lambda(6)-benzoxathiole-1,1(3h)-dione
CHEBI:86155 ,
3,3-bis(3-bromo-4-hydroxy-5-isopropyl-2-methylphenyl)-2,1lambda~6~-benzoxathiole-1,1(3h)-dione
CS-7547
mfcd00005872
3',3''-dibromothymolsulfonphthalein
CHEMBL3392578
bromothymol blue, jis special grade
bromothymol blue, pkg of 200 ml
AS-74554
3,3-bis[3-bromo-4-hydroxy-2-methyl-5-(propan-2-yl)phenyl]-3h-2,1??-benzoxathiole-1,1-dione
bromothymol blue, acs reagent
bromthymolblau
HY-D0012
Q407506
3,3-bis(3-bromo-4-hydroxy-5-isopropyl-2-methylphenyl)-3h-benzo[c][1,2]oxathiole 1,1-dioxide
bromothymol blue (sodium salt)
D88674
2-bromo-4-[3-(3-bromo-4-hydroxy-2-methyl-5-propan-2-ylphenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]-3-methyl-6-propan-2-ylphenol
bleu de bromothymol
blu di bromotimolo
azul de bromotimol
bromothymol blue acs grade free acid
PD063513

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"98 per cent in regard to the substance and its dosage form (gynecological suppositories), respectively."( [A method of quantitative analysis of gentamicin sulfate].
Likhoded, VA; Mukhamedzianov, RM, 1991
)
0.28
" The efflux of paraquat from lung slices prepared from rats dosed intravenously with paraquat was biphasic, having a very fast component and a slow component."( Factors affecting the efflux of paraquat from rat lung slices.
Rose, MS; Smith, LL; Wyatt, I, 1981
)
0.26
" Serum calcium was dosed in duplicate by conventional colorimetric techniques involving o-cresol-phthalein complexone (OCP) or methylthymol blue (MTB) as reagents."( Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents.
Berthommier, C; Corot, C; Devoldere, L; Diai, A; Idee, JM; Lin, J; Port, M; Raynal, I; Robert, M, 1999
)
0.3
" The proposed methods have been applied successfully for the analysis of the drug in its dosage forms."( Extractive spectrophotometric methods for determination of zolmitriptan in tablets.
Aydogmus, Z; Inanli, I,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
acid-base indicatorAn acid or base which exhibits a colour change on neutralization by the basic or acidic titrant at or near the equivalence point of a titration.
dyenull
two-colour indicatorA colour indicator that possesses a different colour on each side of the transition interval.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
2,1-benzoxathiole
arenesulfonate esterAn organosulfonic ester resulting from the formal condensation of an arenesulfonic acid with the hydroxy group of an alcohol, enol, phenol or heteroarenol.
organobromine compoundA compound containing at least one carbon-bromine bond.
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
sultoneAn intramolecular cyclic ester of a hydroxy sulfonic acid, analogous to lactone.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
flap endonuclease 1Homo sapiens (human)Potency50.11870.133725.412989.1251AID588795
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency25.11890.050127.073689.1251AID588590
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1347163384 well plate NINDS AMC confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347169Tertiary RLuc qRT-PCR qHTS assay for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347158ZIKV-mCherry secondary qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347157Confirmatory screen GU Rhodamine qHTS for Zika virus inhibitors qHTS2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347164384 well plate NINDS Rhodamine confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347161Confirmatory screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347149Furin counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347156DAPI mCherry counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (175)

TimeframeStudies, This Drug (%)All Drugs %
pre-199076 (43.43)18.7374
1990's19 (10.86)18.2507
2000's38 (21.71)29.6817
2010's29 (16.57)24.3611
2020's13 (7.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 72.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index72.02 (24.57)
Research Supply Index5.28 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index123.17 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (72.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.03%)5.53%
Reviews1 (0.52%)6.00%
Case Studies1 (0.52%)4.05%
Observational0 (0.00%)0.25%
Other190 (97.94%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]